Results 1 to 10 of about 2,243,245 (285)

Reporting adverse transfusion reactions: A retrospective study from tertiary care hospital from New Delhi, India [PDF]

open access: yesAsian Journal of Transfusion Science, 2017
Context: Blood transfusion services have achieved newer heights in the last decade, with developments in cellular techniques, component separation, and integration of molecular methods. However, the system of recording and reporting of the adverse events
Sangeeta Pahuja   +4 more
doaj   +3 more sources

Recent Advances in Preventing Adverse Reactions to Transfusion [version 1; referees: 4 approved] [PDF]

open access: yesF1000Research, 2015
The spectrum of adverse reactions to blood product transfusion ranges from a benign clinical course to serious morbidity and mortality.  There have been many advances in technologies and transfusion strategies to decrease the risk of adverse reactions ...
Thomas S Rogers   +2 more
doaj   +4 more sources

Bioactive lipids as biomarkers of adverse reactions associated with apheresis platelet concentrate transfusion [PDF]

open access: yesFrontiers in Immunology, 2023
Platelet concentrate (PC) transfusion seeks to provide haemostasis in patients presenting severe central thrombocytopenia or severe bleeding. PCs may induce adverse reactions (AR) that can occasionally be severe (SAR).
Anne-Claire Duchez   +25 more
doaj   +5 more sources

Data from differentially expressed proteins in platelet components associated with adverse transfusion reactions [PDF]

open access: yesData in Brief, 2019
The presented dataset was used for the study focused on the search for differentially expressed proteins in blood platelet components (PCs) associated with adverse transfusion reactions (ATRs).
Chaker Aloui   +7 more
doaj   +2 more sources

Adverse Transfusion Reactions in Critically Ill Patients [PDF]

open access: yesHematologic Problems in the Critically Ill, 2014
Although transfusion therapy in the past 30 years has achieved high levels of safety, severe adverse reactions can still complicate a red blood cell, plasma, or platelet transfusion. Adverse events can be either of infectious nature (Infectious Adverse Reactions to Transfusion–IARTs) or noninfectious (NIARTs).
Tomasella F, Mascaretti L.
europepmc   +2 more sources

Adverse transfusion reactions with respiratory symptoms

open access: yesZdravniški Vestnik, 2012
Background: Quite numerous cases of adverse reactions present with respiratory symptoms, TRALI, TACO and anaphylaxis being the most frequent severe reactions. In our study we describe TACO cases in Slovenia from 2003–2010.
Marjeta Potočnik, Marjeta Maček Kvanka
doaj   +1 more source

Advances in extracorporeal photopheresis

open access: yesZhongguo shuxue zazhi, 2022
Extracorporeal photopheresis(ECP) is a bidirectional cellular immunomodulatory therapy based on leukapheresis, which can mediate not only immunopotentiation but also immunosuppression.
Zhanrui CHENG   +3 more
doaj   +1 more source

Progress in application and detection of riboflavin singlet oxygen photochemistry

open access: yesZhongguo shuxue zazhi, 2022
Photodynamic therapy (PDT), which uses photosensitizers to produce singlet oxygen to kill bacteria, was first discovered by scientists over 100 years ago and has been widely used in clinical treatment.
Yuanyuan HE   +3 more
doaj   +1 more source

Adverse Reactions to Blood ComponentsA Twelve-Year Retrospective StudyA Step towards Prevention [PDF]

open access: yesNational Journal of Laboratory Medicine, 2022
Introduction: The transfusion of blood and blood components is a life-saving procedure in clinical practice. However, it is associated with risks that can range from trivial self-limited Allergic Reactions (AR) to life endangering anaphylactic or ...
C Vidula   +2 more
doaj   +1 more source

Mechanism and transfusion strategy of immunogenic platelet transfusion refractoriness

open access: yesZhongguo shuxue zazhi, 2022
Platelet transfusion is an irreplaceable method to treat patients with platelet reduction in Hematology Department and Oncology Department. However, immunogenic platelet transfusion refractoriness is a huge challenge to patients who require repeatedly ...
Juan SAI, Li TIAN
doaj   +1 more source

Home - About - Disclaimer - Privacy